Navigation Links
Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders
Date:12/5/2009

NEW ORLEANS, Dec. 5 /PRNewswire-USNewswire/ -- Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology introduces potential new treatment options and improved diagnostic methods for patients suffering from acute promyelocytic leukemia, chronic myeloid leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that are based on a better understanding of the underlying genetic causes of these conditions.

"Researchers are committed to improving the survival of patients with blood cancers and other bone marrow disorders like myelofibrosis," said moderator of the press conference Richard A. Larson, MD, Professor of Medicine at the University of Chicago. "We hope that the results of these studies will help us develop safer and more effective treatments, especially in those hard-to-treat conditions where we currently do not have many options."

This press conference will take place on Saturday, December 5, at 8:30 a.m.

Improving the Treatment Outcome of Acute Promyelocytic Leukemia in Developing Countries Through International Cooperative Network. Report on the International Consortium on Acute Promyelocytic Leukemia Study Group [Abstract #6]

In developed countries, the standard treatment for acute promyelocytic leukemia (APL), as recommended by evidence-based guidelines such as those of the EuropeanLeukemiaNET, is a combination of all-trans retinoic acid, a derivative of Vitamin A, and an anthracycline-based chemotherapy; this results in a five-year overall survival rate of approximately 90 percent. The morbidity and mortality of APL in patients in developing countries is significantly higher. Researchers from the International Consortium on Acute Promyelocytic Leukemia (IC-APL), an initiative of the American Society of Hematology, aimed to reduce this difference in surv
'/>"/>

SOURCE American Society of Hematology
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Ovation further advances development pipeline with new phase III epilepsy study
2. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
3. Major grant advances UWs clinical and translational research enterprise
4. Plastic Surgery 2007: Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances
5. Innovation and Medical Advances to be Highlighted on Final Day of Inaugural AdvaMed 2007 Conference
6. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
7. Advances in drug screening: building a better haystack for the needles of tomorrow
8. Advances in Cancer Research, Funding Stem Cell Research, and More at Annual Cancer Congress
9. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
10. Springer adds Advances in Therapy to journals portfolio
11. NIH grant advances dentistry schools work on psychosocial stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... As obesity rates sky rocket in the ... equipment during childbirth comes as no shock. Forceps are surgical ... when she is unable to do so herself and although ... higher rates of complication for both the mother and the ... mother and child, forceps births add to the pressure of ...
(Date:6/18/2013)... SEATTLE, WA—A Washington state resident filed ... claiming he fell ill with a hepatitis A infection ... blend. The complaint was filed in Snohomish County ... Seattle-based law firm that has filed 14 previous ... complaint, Brian Brothers consumed “Townsend Farms Organic Antioxidant Blend” ...
(Date:6/18/2013)... The Drug Delivery Partnering Terms and Agreements ... drug delivery partnering deals and agreements entered into by ... provides a detailed understanding and analysis of how and ... of deals are discovery or development stage whereby the ... license the license drug delivery technology. These deals tend ...
(Date:6/18/2013)... The Temp1000IS temperature data logger is ... be used to automatically record temperatures between -20 and ... comes with the serial number and device name engraved. ... separately) docking station and can be placed directly into ... of end-caps to download data. The small size of ...
(Date:6/18/2013)... 2013 Parker Waichman LLP , ... of victims injured by defective medical devices, reports that ... Infuse bone graft products are now available. Published this ... the two studies serve up two key findings: There ... Infuse and the traditional bone graft; and there is ...
Breaking Medicine News(10 mins):Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3
... the fight against HIV and they must be given ... a new commentary published today in the journal Nature ... who are evaluating multiple candidate vaccines designed to prevent ... commit to sharing technology and expertise with those in ...
... Tufts University School of Medicine in collaboration with ... created a computer program called Pathogen Simulation (PathSim) ... in humans. David Thorley-Lawson, PhD, professor of pathology ... PathSim, laboratory methods, and clinical studies to provide ...
... MA- Mayor Michael R. Bloomberg of New York ... Julius B. Richmond Award, the highest honor given by ... of bold initiatives that recognize public health as a ... extraordinary leadership in protecting and promoting the health of ...
... is the latest American Chemical Society (ACS) News Service ... journals and Chemical & Engineering News. With more than,160,000 ... the individual journal, or the American Chemical Society, as ... #1 FOR IMMEDIATE RELEASE , , Excess female ...
... at the University of Pennsylvania School of Medicine have ... affecting the prognosis of patients with head and neck ... issue of CANCER. , The belief that a patients ... their cancer is one that has been prominent among ...
... 100,000 California seniors finds too few health tests , ... care received by vulnerable elderly Medicare, Medicaid patients is ... Researchers at the University of California, Los Angeles, used ... of Vulnerable Elders project to look at 43 specific ...
Cached Medicine News:Health News:Fight against HIV needs local scientists, say researchers 2Health News:Epstein-Barr: a virtual look at a vexing virus 2Health News:Bloomberg receives award for promotion of health in NYC and nation 2Health News:Bloomberg receives award for promotion of health in NYC and nation 3Health News:Bloomberg receives award for promotion of health in NYC and nation 4Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 2Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 3Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 4Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 5Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 6Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 7Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 8Health News:Penn researchers find emotional well-being has no influence on cancer survival 2Health News:Most Elderly Don't Get Good Medical Care: Study 2
(Date:6/18/2013)... 18, 2013 Today, Wall Street Reports ... GILD ), Health Management Associates Inc. (NYSE: ... ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), and Trius ... free of charge - including full price targets, industry analysis ... Gilead Sciences, Inc. Research Report On June 7, ...
(Date:6/18/2013)... , June 18, 2013 Apama ... on the development of next-generation atrial fibrillation technologies, ... 8295902 by the US Patent and Trademark Office ... low profile electrode assemblies for use on expandable ... or other surgical procedures. "We are ...
(Date:6/17/2013)... , June 17, 2013 Velplex, LLC announced ... a technology platform that connects buyers and sellers of ... an industry leader. Why? It,s because ... are intimately familiar with the dental industry. They have ... and have diligently worked to negotiate some of the ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... diagnosis of influenza A and ... due to the availability of ... of influenza using Clearview Exact ... lead to reduced hospital stays, ...
... A1c-Cellular is the first HbA1c control available ... the entire HbA1c procedure including the lysing ... is a ready-to-use liquid control with an ... closed-vial stability of six months when refrigerated. ...
...
Medicine Products: